4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin.
The efficacy and safety of a 4-week course of intravenous teicoplanin (500 mg every 12 h for the first 2 days and 10 mg/kg of body weight every 24 h thereafter) in the treatment of streptococcal native valve endocarditis in 20 patients were evaluated. All blood isolates were inhibited by a concentra...
Guardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1992
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189370/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1386972/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.4.723 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|